Doctor casts doubt on COVID plasma treatment: ‘No breakthrough here’
In This Article:
Late Sunday night, President Trump announced that the Food and Drug Administration (FDA) authorized emergency use of convalescent plasma to treat COVID-19, the illness caused by the coronavirus.
"Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives," President Trump said during a White House press briefing. "Today's action will dramatically increase access to this treatment."
However, some health experts have questioned the FDA’s action to issue an emergency use authorization (EUA) and whether or not the organization was pressured by the Trump administration into authorizing the treatment too soon, along with the idea of touting it as a medical breakthrough.
“The use of convalescent plasma for infections has been around for 100 years,” Dr. Dara Kass, an associate professor of emergency medicine at Columbia University, said on Yahoo Finance’s The First Trade (video above). “There’s no breakthrough here … even with convalescent plasma being used for the coronavirus.
“The data that is being used by the FDA to put this EUA through is not strong and really has been manipulated, we think, a little bit just to prove a benefit that actually isn’t even between people that didn’t get plasma but really between people that got it before three days and got it after three days,” she continued.
‘What would they do for a vaccine?’
During Sunday’s press briefing, current FDA Commissioner Stephen Hahn denied that the decision came under pressure and said it was made in “independent judgment” of those at the FDA.
“Those scientists have concluded that COVID-19 convalescent plasma is safe and shows promising efficacy, thereby meeting the criteria for an emergency use authorization,” Hahn said.
Trump claimed during the briefing that convalescent plasma reduced mortality by 35%, although this has proven to be unfounded.
According to Dr. Kass, this “brings up some questions about really just where they got that information from and why it meant that there was a huge breakthrough yesterday when in fact nothing had really changed.”
Convalescent plasma works by being taken from those who have already recovered from the coronavirus and have the antibodies, and then purified and administered to those currently battling the virus. From there, the body uses those antibodies to fight off the infection. This treatment has been used on more than 70,000 patients so far, with successful results.
“Plasma is safe and every study that’s been done has shown that it’s safe,” Kass said. The bigger concern, however, “is that if the administration is interested in bullying the FDA to pass an EUA for the plasma, what would they do for a vaccine? And I think the fact that news came out in less than 12 hours from the EUA for the plasma that there may actually be movement towards a vaccine to do the same thing is concerning. Vaccine development has never been done this fast.”